| Preoperative embolization of intracranial arteriovenous malformations with Onyx. | |
| | |
MedLine Citation:
|
PMID: 17762736 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: Preoperative embolization in accordance with multimodal therapies for cerebral arteriovenous malformations (AVMs) is generally the first step in treatment and may result in complete obliteration. The Onyx liquid embolic system (Micro Therapeutics, Inc., Irvine, CA) may offer advantages for intranidal targeted embolization and microsurgical resection. We present our experience in the combined treatment of intracranial AVMs using Onyx embolization and neurosurgical resection. METHODS: We treated a total of 47 patients for compact intracranial AVMs that were located in the frontal or frontoparietal area (16 patients); temporal, temporoparietal, or temporo-occipital regions (12 patients); parietal or parieto-occipital areas (8 patients); occipital regions (8 patients); had basal ganglia involvement (2 patients); and was cerebellar (1 patient). The Spetzler-Martin grading scale values were as follows: 25 patients were Grades I or II, 10 patients were Grade III, and 12 patients were Grades IV or V. Twenty-three AVMs were located in eloquent brain regions. RESULTS: After we performed final embolizations, the mean nidus reduction was 84%. Seven patients had new, nondisabling neurological deficits, and four patients had new, disabling neurological deficits after embolization. Periprocedurally, five vessel perforations and four stuck microcatheters were encountered without clinical deficits. In two patients, delayed hemorrhage after embolization occurred with good clinical outcome. We completely resected 46 AVMs; in one patient, we detected an AVM on postoperative angiography. The mean operative time was 4.7 hours, and the mean blood loss was 455 mL. Clinical status worsened postoperatively in 14 patients. Angiographic and clinical follow-up examinations were available for 42 patients (89%); the average follow-up period was 13 months. We found no relapse of arteriovenous shunt. Fourteen patients improved clinically after discharge. Of the 42 patients followed up, 23 individuals had no neurological deficit, 16 had a nondisabling deficit, and three had a disabling deficit. CONCLUSION: Preoperative use of the Onyx liquid embolic system in cerebral AVM treatment allows profound occlusion by targeted embolization and provides a basis for safe neurosurgical resection. |
| | |
Authors:
|
Werner Weber; Bernhard Kis; Ralf Siekmann; Paul Jans; Rudolf Laumer; Dietmar Kühne |
Related Documents
:
|
16254396 - Transcranial sonographic monitoring of hemorrhagic transformation in patients with acut... 15936506 - Cerebral glucose metabolism in corticobasal degeneration comparison with progressive su... 16438006 - Spontaneous intraoperative hypothermia and cerebral protection in aneurysmal subarachno... 7198196 - Cerebellar atrophy: relationship to aging and cerebral atrophy. 6109866 - Hypercalcaemia in hospital patients. clinical and diagnostic aspects. 6728546 - Radiological findings in total aganglionosis coli. |
Publication Detail:
|
Type: Clinical Trial; Journal Article |
Journal Detail:
|
Title: Neurosurgery Volume: 61 ISSN: 1524-4040 ISO Abbreviation: Neurosurgery Publication Date: 2007 Aug |
Date Detail:
|
Created Date: 2007-08-31 Completed Date: 2007-09-25 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7802914 Medline TA: Neurosurgery Country: United States |
Other Details:
|
Languages: eng Pagination: 244-52; discussion 252-4 Citation Subset: IM |
Affiliation:
|
Department of Radiology and Neuroradiology, Alfried Krupp Hospital, Essen, Germany. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adolescent Adult Cerebral Angiography Child Combined Modality Therapy Dimethyl Sulfoxide* Embolization, Therapeutic / methods* Female Follow-Up Studies Humans Intracranial Arteriovenous Malformations / surgery*, therapy* Male Middle Aged Neurosurgical Procedures* Polyvinyls* Postoperative Complications / radiography Preoperative Care Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Onyx copolymer; 0/Polyvinyls; 67-68-5/Dimethyl Sulfoxide |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: A 7-year experience with balloon-mounted coronary stents for the treatment of symptomatic vertebroba...
Next Document: Early plasma complement C3a levels correlate with functional outcome after aneurysmal subarachnoid h...